Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes - PubMed (original) (raw)

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

Y Kawakami et al. J Exp Med. 1994.

Abstract

Four melanoma proteins, MART-1, gp100, tyrosinase, and tyrosinase-related protein-1 (gp75) were evaluated for recognition by HLA-A2-restricted melanoma-specific cytotoxic T lymphocytes (CTLs) derived from the tumor-infiltrating lymphocytes (TIL) of 10 different patients. 9 of 10 TIL recognized MART-1, 4 recognized gp100 (including 3 that also recognized MART-1), but none of the TIL recognized tyrosinase or gp75. Based on the known HLA-A2.1 peptide binding motifs, 23 peptides from MART-1 were synthesized in an attempt to identify the epitopes recognized by TIL. Three peptides were recognized by TIL when pulsed on T2 target cells. One of the 9-mer peptides, AAGIGILTV, was most effective in sensitizing the T2 cells for TIL lysis. This peptide was recognized by 9 of 10 HLA-A2-restricted melanoma-specific CTLs. Therefore, this peptide appears to be a very common immunogenic epitope for HLA-A2-restricted melanoma-specific TIL and may be useful for the development of immunotherapeutic strategies.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1992 Nov 1;176(5):1453-7 - PubMed
    1. J Exp Med. 1988 Dec 1;168(6):2183-91 - PubMed
    1. J Immunol. 1993 Apr 1;150(7):2955-63 - PubMed
    1. J Exp Med. 1993 Apr 1;177(4):989-98 - PubMed
    1. J Immunol. 1993 Aug 1;151(3):1410-8 - PubMed

MeSH terms

Substances

LinkOut - more resources